The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals

REFERENCES

• FarrandE, ShahR, CollardH. The hospitalized patient with interstitial lung disease: a hospitalist primer. J Hosp Med. 2017;12(7):580–584. doi:10.12788/jhm.2774.
   PubMed Web of Science ®Google Scholar
• VillarJ, ZhangH, SlutskyAS. Lung repair and regeneration in ARDS: role of PECAM1 and Wnt signaling. Chest 2019;155(3):587–594. doi:10.1016/j.chest.2018.10.022.
   PubMed Web of Science ®Google Scholar
• TianC, ZhangP, YangJ, et al. The protective effect of the flavonoid fraction of Abutilon theophrasti Medic. leaves on LPS-induced acute lung injury in mice via the NF-kappaB and MAPK signalling pathways. Biomed Pharmacother. 2019;109:1024–1031. doi:10.1016/j.biopha.2018.10.197.
   PubMed Web of Science ®Google Scholar
• LiuJX, LiX, YanFG, et al. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-kappaB pathway. Int Immunopharmacol. 2019;66:336–346. doi:10.1016/j.intimp.2018.11.033.
   PubMed Web of Science ®Google Scholar
• FeiJ, FuL, HuB, et al. Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice. Int Immunopharmacol. 2019;66:177–184. doi:10.1016/j.intimp.2018.11.005.
   PubMed Web of Science ®Google Scholar
• GuoS, JiangK, WuH, et al. Magnoflorine ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-kappaB and MAPK activation. Front Pharmacol. 2018;9:982.
   PubMed Web of Science ®Google Scholar
• DingX, TongY, JinS, et al. Mechanical ventilation enhances extrapulmonary sepsis-induced lung injury: role of WISP1-alphavbeta5 integrin pathway in TLR4-mediated inflammation and injury. Crit Care. 2018;22(1):302. doi:10.1186/s13054-018-2237-0.
   PubMed Web of Science ®Google Scholar
• TanJ, LiL, ShiW, et al. Protective effect of 2-hydroxymethyl anthraquinone from Hedyotis diffusa willd in lipopolysaccharide-induced acute lung injury mediated by TLR4-NF-κB pathway. Inflammation 2018;41(6):2136–2148. doi:10.1007/s10753-018-0857-9.
   PubMed Web of Science ®Google Scholar
• DuZA, SunMN, HuZS. Saikosaponin a ameliorates LPS-induced acute lung injury in mice. Inflammation 2018;41(1):193–198. doi:10.1007/s10753-017-0677-3.
   PubMed Web of Science ®Google Scholar
• PinkertonJW, KimRY, RobertsonAAB, et al. Inflammasomes in the lung. Mol Immunol. 2017;86:44–55. doi:10.1016/j.molimm.2017.01.014.
   PubMed Web of Science ®Google Scholar
• LiuZ, QuM, YuL, SongP, ChangY. Artesunate inhibits renal ischemia-reperfusion-mediated remote lung inflammation through attenuating ROS-induced activation of NLRP3 inflammasome. Inflammation 2018;41(4):1546–1556. doi:10.1007/s10753-018-0801-z.
   PubMed Web of Science ®Google Scholar
• HeHQ, WuYX, NieYJ, et al. LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway. Acta Pharmacol Sin. 2017;38(3):342–350. doi:10.1038/aps.2016.141.
   PubMed Web of Science ®Google Scholar
• MengL, LiL, LuS, et al. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Mol Immunol. 2018;94:7–17. doi:10.1016/j.molimm.2017.12.008.
   PubMed Web of Science ®Google Scholar
• GaoZ, LiuX, WangW, et al. Characteristic anti-inflammatory and antioxidative effects of enzymatic- and acidic-hydrolysed mycelium polysaccharides by Oudemansiella radicata on LPS-induced lung injury. Carbohydr Polym. 2019;204:142–151. doi:10.1016/j.carbpol.2018.09.073.
   PubMed Web of Science ®Google Scholar
• DingH, CiX, ChengH, YuQ, LiD. Chicoric acid alleviates lipopolysaccharide-induced acute lung injury in mice through anti-inflammatory and anti-oxidant activities. Int Immunopharmacol. 2019;66:169–176. doi:10.1016/j.intimp.2018.10.042.
   PubMed Web of Science ®Google Scholar
• XingJ, YuZ, ZhangX, et al. Epicatechin alleviates inflammation in lipopolysaccharide-induced acute lung injury in mice by inhibiting the p38 MAPK signaling pathway. Int Immunopharmacol. 2019;66:146–153. doi:10.1016/j.intimp.2018.11.016.
   PubMed Web of Science ®Google Scholar
• JiangJ, JianQ, JingM, et al. The novel N-methyl-d-aspartate receptor antagonist MN-08 ameliorates lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2019;66:109–118. doi:10.1016/j.intimp.2018.11.010.
   PubMed Web of Science ®Google Scholar
• JiaX, CaoB, AnY, ZhangX, WangC. Rapamycin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting IL-1beta and IL-18 production. Int Immunopharmacol. 2019;67:211–219. doi:10.1016/j.intimp.2018.12.017.
   PubMed Web of Science ®Google Scholar
• XuX, LiH, GongY, ZhengH, ZhaoD. Hydrogen sulfide ameliorated lipopolysaccharide-induced acute lung injury by inhibiting autophagy through PI3K/Akt/mTOR pathway in mice. Biochem Biophys Res Commun. 2018;507(1–4):514–518. doi:10.1016/j.bbrc.2018.11.081.
   PubMed Web of Science ®Google Scholar
• CaoC, YinC, ShouS, et al. Ulinastatin protects against LPS-induced acute lung injury by attenuating TLR4/NF-κB pathway activation and reducing inflammatory mediators. Shock. 2018;50(5):595–605. doi:10.1097/SHK.0000000000001104.
   PubMed Web of Science ®Google Scholar
• JuM, LiuB, HeH, et al. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Cell Cycle. 2018;17(16):2001–2018. doi:10.1080/15384101.2018.1509635.
   PubMed Web of Science ®Google Scholar
• LiW, LiW, ZangL, et al. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-kappaB and NLRP3 signalling pathways. Int Immunopharmacol. 2019;67:1–12. doi:10.1016/j.intimp.2018.12.003.
   PubMed Web of Science ®Google Scholar
• HanX, WuYC, MengM, et al. Linarin prevents LPSinduced acute lung injury by suppressing oxidative stress and inflammation via inhibition of TXNIP/NLRP3 and NFkappaB pathways. Int J Mol Med. 2018;42:1460–1472. doi:10.3892/ijmm.2018.3710.
   PubMed Web of Science ®Google Scholar
• LiY, XiaoJ, TanY, et al. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-kappaB pathway in mice. Immunopharmacol Immunotoxicol. 2017;39(4):165–172. doi:10.1080/08923973.2017.1303839.
   PubMed Web of Science ®Google Scholar
• WeifengY, LiL, YujieH, et al. Inhibition of acute lung injury by TNFR-Fc through regulation of an inflammation-oxidative stress pathway. PLoS One. 2016;11(3):e0151672. doi:10.1371/journal.pone.0151672.
   PubMed Web of Science ®Google Scholar
• HassanN, AliA, WithycombeC, et al. TET-2 up-regulation is associated with the anti-inflammatory action of Vicenin-2. Cytokine. 2018;108:37–42. doi:10.1016/j.cyto.2018.03.016.
   PubMed Web of Science ®Google Scholar
• DongZ, YuanY. Accelerated inflammation and oxidative stress induced by LPS in acute lung injury: Iotanhibition by ST1926. Int J Mol Med. 2018;41:3405–3421. doi:10.3892/ijmm.2018.3574.
   PubMed Web of Science ®Google Scholar
• LiuT, ZhouY, LiP, et al. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Sci Rep. 2016;6(1):39473. doi:10.1038/srep39473.
   PubMed Web of Science ®Google Scholar
• LuoM, HuL, LiD, et al. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-kappaB-dependent pathway in alveolar macrophages cell line. Mol Immunol. 2017;90:1–10. doi:10.1016/j.molimm.2017.06.035.
   PubMed Web of Science ®Google Scholar
• LiY, LiH, LiuS, et al. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Mol Immunol. 2018;99:134–144. doi:10.1016/j.molimm.2018.05.003.
   PubMed Web of Science ®Google Scholar
• JiangL, ZhangL, KangK, et al. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation. Biomed Pharmacother. 2016;84:130–138. doi:10.1016/j.biopha.2016.09.020.
   PubMed Web of Science ®Google Scholar
• ZhongWJ, YangHH, GuanXX, et al. Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model. J Cell Physiol. 2019;234(4):4641–4654. doi:10.1002/jcp.27261.
   PubMed Web of Science ®Google Scholar
• JiangL, FeiD, GongR, et al. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury. Inflamm Res. 2016;65(11):905–915. doi:10.1007/s00011-016-0973-7.
   PubMed Web of Science ®Google Scholar